NO20003245D0 - <Kappa>-reseptor-opoid-peptider - Google Patents

<Kappa>-reseptor-opoid-peptider

Info

Publication number
NO20003245D0
NO20003245D0 NO20003245A NO20003245A NO20003245D0 NO 20003245 D0 NO20003245 D0 NO 20003245D0 NO 20003245 A NO20003245 A NO 20003245A NO 20003245 A NO20003245 A NO 20003245A NO 20003245 D0 NO20003245 D0 NO 20003245D0
Authority
NO
Norway
Prior art keywords
kappa
opioid peptides
receptor opioid
receptor
peptides
Prior art date
Application number
NO20003245A
Other languages
English (en)
Other versions
NO327080B1 (no
NO20003245L (no
Inventor
Jean Louis Junien
Pierre J M Riviere
Claudio D Schteingart
Javier Sueiras Diaz
Jerzy A Trojnar
Todd W Vanderah
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO20003245D0 publication Critical patent/NO20003245D0/no
Publication of NO20003245L publication Critical patent/NO20003245L/no
Publication of NO327080B1 publication Critical patent/NO327080B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20003245A 1997-12-23 2000-06-21 Syntetisk opioidpeptidamid samt et farmasoytisk preparat NO327080B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/997,208 US5965701A (en) 1997-12-23 1997-12-23 Kappa receptor opioid peptides
PCT/US1998/027282 WO1999032510A1 (en) 1997-12-23 1998-12-22 Kappa receptor opioid peptides

Publications (3)

Publication Number Publication Date
NO20003245D0 true NO20003245D0 (no) 2000-06-21
NO20003245L NO20003245L (no) 2000-08-23
NO327080B1 NO327080B1 (no) 2009-04-20

Family

ID=25543752

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003245A NO327080B1 (no) 1997-12-23 2000-06-21 Syntetisk opioidpeptidamid samt et farmasoytisk preparat

Country Status (32)

Country Link
US (1) US5965701A (no)
EP (1) EP1042359B1 (no)
JP (1) JP4275852B2 (no)
KR (1) KR100629548B1 (no)
CN (1) CN1154655C (no)
AR (1) AR014167A1 (no)
AT (1) ATE301670T1 (no)
AU (1) AU747806B2 (no)
BR (2) BR9814499B1 (no)
CA (1) CA2315878C (no)
CR (1) CR5936A (no)
CZ (1) CZ297281B6 (no)
DE (1) DE69831176T2 (no)
DK (1) DK1042359T3 (no)
EE (1) EE04440B1 (no)
ES (1) ES2247735T3 (no)
HR (1) HRP20000415B1 (no)
HU (1) HU227640B1 (no)
IL (3) IL136742A0 (no)
MY (1) MY117542A (no)
NO (1) NO327080B1 (no)
NZ (1) NZ505183A (no)
PL (1) PL195842B1 (no)
PT (1) PT1042359E (no)
RU (1) RU2217437C2 (no)
SK (1) SK286135B6 (no)
TR (1) TR200001985T2 (no)
TW (1) TW580502B (no)
UA (1) UA68366C2 (no)
UY (1) UY25327A1 (no)
WO (1) WO1999032510A1 (no)
ZA (1) ZA9811801B (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
WO2001036006A1 (en) * 1999-11-19 2001-05-25 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
DE10116978A1 (de) * 2001-04-05 2002-10-10 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
WO2002089845A1 (fr) * 2001-05-08 2002-11-14 Toray Industries, Inc. Remedes contre la sepsie
US6923175B2 (en) 2002-03-20 2005-08-02 Mannkind Corporation Inhalation apparatus
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
MX373000B (es) 2005-09-14 2020-05-21 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
CA2653072A1 (en) * 2006-05-26 2007-12-06 Cara Therapeutics, Inc. Method for elevating prolactin in mammals
CN101454338A (zh) * 2006-05-26 2009-06-10 卡拉治疗学股份有限公司 κ阿片样受体肽的N-氧化物
US7713937B2 (en) * 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
MX2009005000A (es) 2006-11-10 2009-10-12 Cara Therapeutics Inc Amidas de peptidos sinteticos.
US7842662B2 (en) * 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US8906859B2 (en) * 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US8236766B2 (en) * 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
WO2008077194A1 (en) * 2006-12-22 2008-07-03 Xenome Ltd Receptor agonists
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CN101827626B (zh) 2008-06-13 2015-03-18 曼金德公司 干粉吸入器和用于药物输送的系统
ES2421385T3 (es) 2008-06-20 2013-09-02 Mannkind Corp Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
KR102584844B1 (ko) 2009-06-12 2023-10-04 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
CN102985125A (zh) 2010-06-21 2013-03-20 曼金德公司 干粉药物输送系统和方法
SG194034A1 (en) 2011-04-01 2013-11-29 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
MX2014004983A (es) * 2011-10-24 2014-09-22 Mannkid Corp Metodos y composiciones para tratar dolor.
KR102264177B1 (ko) 2012-07-12 2021-06-11 맨카인드 코포레이션 건조 분말 약물 전달 시스템 및 방법
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
EP3587404B1 (en) 2013-03-15 2022-07-13 MannKind Corporation Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
CA2953653C (en) * 2014-06-26 2021-02-16 Maruishi Pharmaceutical Co., Ltd. Method for producing synthetic pentapeptide
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10550150B2 (en) * 2015-05-11 2020-02-04 Cadila Healthcare Limited Short-chain peptides as Kappa (κ) opioid receptors (KOR) agonist
CN107098876B (zh) * 2016-02-23 2021-04-06 江苏恒瑞医药股份有限公司 苯基丙酰胺类衍生物、其制备方法及其在医药上的应用
US11084847B2 (en) 2016-09-27 2021-08-10 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Polyamide compound and use thereof
EP3656782B1 (en) * 2017-07-21 2021-12-22 Sichuan Haisco Pharmaceutical Co., Ltd. Peptide amide compound and preparation method and medical use thereof
CA3084201A1 (en) 2017-12-06 2019-06-13 Jiangsu Hengrul Medicine Co., Ltd. Salt of phenylpropionamide derivative and preparation method therefor
WO2019219019A1 (zh) 2018-05-16 2019-11-21 江苏恒瑞医药股份有限公司 一种kor受体激动剂药物组合物
CN114127086B (zh) * 2019-07-25 2023-10-20 四川海思科制药有限公司 氘代肽酰胺类化合物及其制备方法和在医药上的用途
CN114127085B (zh) * 2019-07-25 2024-08-13 西藏海思科制药有限公司 一种肽酰胺盐及其制备方法和在医药上的用途
US12215173B2 (en) 2019-08-07 2025-02-04 HUMANWELL PHARMACEUTICAL US, Inc. Kappa opioid receptor peptide amide ligands
KR20230024419A (ko) 2020-06-25 2023-02-20 휴먼웰 파마슈티컬 유에스 의학적 장애 치료용 펩티드
US20240336565A1 (en) 2021-07-02 2024-10-10 Acer Therapeutics, Inc. Solid forms of osanetant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2013689B (en) * 1977-12-15 1982-03-24 Reckitt & Colmann Prod Ltd Compounds
GB8801304D0 (en) * 1988-01-21 1988-02-17 Ici Plc Diamine compounds
US5367053A (en) * 1993-05-19 1994-11-22 Houghten Pharmaceuticals, Inc. Opioid peptide inhibitors
RU2067000C1 (ru) * 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US5610271A (en) * 1995-06-07 1997-03-11 Torrey Pines Institute For Molecular Studies Kappa receptor selective opioid peptides

Also Published As

Publication number Publication date
BRPI9814499B8 (pt) 2021-11-09
EE200000370A (et) 2001-10-15
EP1042359A1 (en) 2000-10-11
BRPI9814499A (pt) 2000-10-10
IL178471A0 (en) 2007-02-11
JP4275852B2 (ja) 2009-06-10
MY117542A (en) 2004-07-31
UY25327A1 (es) 2000-12-29
HUP0100626A3 (en) 2001-12-28
HUP0100626A2 (hu) 2001-08-28
KR100629548B1 (ko) 2006-09-27
PT1042359E (pt) 2005-11-30
BR9814499A (pt) 2000-10-10
CA2315878A1 (en) 1999-07-01
CZ297281B6 (cs) 2006-10-11
SK286135B6 (sk) 2008-04-07
TR200001985T2 (tr) 2000-11-21
DE69831176T2 (de) 2006-04-20
WO1999032510A1 (en) 1999-07-01
EE04440B1 (et) 2005-02-15
US5965701A (en) 1999-10-12
ES2247735T3 (es) 2006-03-01
PL195842B1 (pl) 2007-10-31
NO327080B1 (no) 2009-04-20
CA2315878C (en) 2010-11-16
RU2217437C2 (ru) 2003-11-27
HRP20000415B1 (en) 2004-06-30
KR20010033450A (ko) 2001-04-25
SK9602000A3 (en) 2001-01-18
ZA9811801B (en) 1999-06-22
TW580502B (en) 2004-03-21
BRPI9814499B1 (pt) 2014-10-21
DK1042359T3 (da) 2005-11-28
NZ505183A (en) 2001-09-28
ATE301670T1 (de) 2005-08-15
CN1154655C (zh) 2004-06-23
CR5936A (es) 2006-08-18
JP2001526295A (ja) 2001-12-18
AR014167A1 (es) 2001-02-07
CN1283201A (zh) 2001-02-07
AU1940299A (en) 1999-07-12
WO1999032510A9 (en) 1999-09-23
DE69831176D1 (de) 2005-09-15
NO20003245L (no) 2000-08-23
PL341308A1 (en) 2001-04-09
IL136742A0 (en) 2001-06-14
BR9814499B1 (pt) 2014-10-21
UA68366C2 (en) 2004-08-16
HK1029349A1 (en) 2001-03-30
IL136742A (en) 2006-12-31
AU747806B2 (en) 2002-05-23
CZ20002382A3 (cs) 2000-12-13
EP1042359B1 (en) 2005-08-10
HU227640B1 (en) 2011-10-28
HRP20000415A2 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
NO20003245D0 (no) &lt;Kappa&gt;-reseptor-opoid-peptider
DE69617699D1 (de) Neuartige opioid-peptide
DE69833073D1 (de) CCR-3-Rezeptor-Antagonisten
NO982097L (no) Peptider
NO982098L (no) Peptider
DE69812096D1 (de) Neuropeptid y rezeptorantagonisten
ID21702A (id) Sistim dispenser
ID23168A (id) Reseptor anatagonis vitronektin
ID24726A (id) Antagonis-antagonis reseptor trombin
NO20001514D0 (no) Vitronectin-reseptor-antagonist
ID24162A (id) Antagonis-antagonis reseptor vitronektin
NO20001515D0 (no) Vitronektin reseptor-antagonist
NO981454L (no) Anti-FAS-antistoffer
DE69824837D1 (de) Il-8-rezeptor-antagonisten
ATE303370T1 (de) Il-8 rezeptor antagonisten
DE69732715D1 (de) Tachykinin antagoniste
NO20012283D0 (no) Koblede peptider
NO20013933D0 (no) Peptider
SI1042359T1 (sl) Kappa receptorski opioidni peptidi
EP1151100A4 (en) TAU-CONOTOXIN PEPTIDE
DK1017798T3 (da) Lunasinpeptider
NO20000976D0 (no) Peptider
DE69830671D1 (de) Integrin-rezeptor-antagonisten
IT243063Y1 (it) Fissaggio per ombrellone
SE9802536D0 (sv) Novel peptides

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees